Studies have found that globular adiponectin (gAcrp) can inhibit the activation of leptin inflammatory bodies through heme oxygenase-1 (HO-1) signaling, thus preventing the cancer-promoting effect of leptin (160). The gene discussed is ADIPOQ; the disease is cancer.